Image

Coaching Dementia Caregivers to Master Care-Resistant Behavior

Recruiting
18 - 95 years of age
Both
Phase N/A

Powered by AI

Overview

266 family caregivers will be randomly assigned to either immediate intervention or delayed intervention groups. All caregivers will complete baseline surveys and 3 weeks of daily diaries. The immediate intervention group will receive 12 weeks of CuRB-IT. They will complete 3 rounds of 3-week daily diaries followed by an intermittent survey at 12 week intervals for the next 33 weeks. The delayed intervention group will receive 12 weeks of attention, complete 1 round of 3-week daily diaries followed by an intermittent survey, then complete 12 weeks of CuRB-IT, and complete 2 rounds of 3--week daily diaries followed by an intermittent survey at 12-week intervals for the next 18 weeks.

Description

The purposes of the delayed-intervention randomized clinical trial (N=266) are to:

Care-Resistant Behavior Internet Training (CuRB-IT).

  1. examine the efficacy of CuRB-IT in increasing the self-efficacy of family caregivers of persons living with dementia to handle care-resistant behaviors (CRB);
  2. further test the efficacy of CuRB-IT in improving caregivers coping strategies (a) among the experimental (immediate-intervention group) as compared to the control (delayed-intervention group) (between groups) and (b) within-person from pre- to post- intervention;
  3. examine intervention decay at 3- and 6-months post intervention to determine performance of intervention and inform scheduling of booster sessions;
  4. assess the efficacy of the CuRB-IT intervention in preventing onset of poor coping strategies by family caregivers;
  5. test the hypothesized mechanism of action that increased CRB self-efficacy and use of CuRB-IT problem-focused coping strategies mediate the relationship between CRB stress appraisal and caregiving activities.

Eligibility

Inclusion Criteria:

  • 1)Caregiver of any race or gender who is aged >18 years

-

2) provides unpaid care,

-

       3) cares for a spouse/common-law, sibling, parent or grandparent (or in-law, aged
          60+ years),

-

4) lives with or shares cooking facilities with the care recipient,

-

       5) Care recipient has mild cognitive impairment or dementia as identified using
          the Quick Dementia Rating System instrument,

-

       6) the care provided consists of help with at least 2 Instrumental Activities of
          Daily Living or one Activity of Daily Living,

-

       7) the care recipient is resistant to receiving assistance with, or refuses to do,
          at least one instrumental or activity of daily living

Exclusion Criteria:

-

  1. persons who cannot speak/read English

-

2) who do not have reliable access to a smart phone or internet

Study details

Care-resistant Behavior, Dementia

NCT05098652

University of Alabama at Birmingham

5 May 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.